Abstract Maresin 1 (MaR1) confers brain-protective effects against cerebral ischemia/reperfusion(I/R) injury. Activation of silent information regulator 1 (SIRT1) signaling has also been demonstrated to inhibit cerebral I/R injury. We hypothesize that MaR1 may protect against cerebral I/R injury by activating SIRT1 signaling. The present study investigated the protective effect of MaR1 treatment on cerebral I/R injury and elucidated the potential mechanisms. Mice were exposed to the treatment in the presence or absence of MaR1 or the SIRT1 inhibitor EX527 and then subjected to the middle cerebral artery occlusion (MCAO) operation. MaR1 conferred a brain-protective effect by up-regulating SIRT1 and Bcl2 expression, down-regulating acetylated neuclear factor kappaB (AC-NF-κB) and Bax expression, reducing pro-inflammatory factor levels (IL-1, IL-6 and TNF-α), increasing the mitochondrial membrane potential, and diminishing neuronal degeneration, the infarct size and the neurological defects of cerebral I/R. These protective effects were partially blocked by the SIRT1 inhibitor EX527, indicating that SIRT1 signaling might be specifically involved in the protection provided by MaR1 against cerebral I/R injury. In summary, our results demonstrate that MaR1 treatment attenuates cerebral I/R injury by reducing inflammatory responses and mitochondrial damage via activation of SIRT1 signaling.
Introduction
Cerebral ischemia and reperfusion leads to extensive damage and is a substantial medical burden due to the ensuing mortality and morbidity (Mozaffarian et al., 2016) . In adults, thrombotic occlusion of a blood vessel induces a stroke, which is typically a cause of ischemic insult to the brain (Sanderson et al., 2013) . The effective strategies for treating ischemic injuries are restoring blood flow and delivering oxygen to the ischemic brain. However, reperfusion itself can cause additional and severe brain damage, which is termed reperfusion injury (Carden and Granger, 2000) . The effect of cerebral ischemia/reperfusion(I/R) injury on patient mortality is sizable irrespective of age or etiology.
A number of studies have explored the potential mechanism of cerebral I/R injury (Marlier et al., 2015; Sun et al., 2003) . The pathogenesis of cerebral I/R is complex and involves a series of distinct molecular pathways. Inflammatory reactions have been implicated as a prominent injury mechanism (Langhauser et al., 2012) .
Inflammation may contribute to secondary brain damage during the development of cerebral I/R, which is considered the main cause of ischemic injury (Han et al., 2015) .
Therefore, blocking various aspects of the inflammatory reactions may be effective in mitigating ischemic injury (Ye et al., 2010) . The mitochondria are the source of energy for sustaining life and are involved in the majority of physiological processes, including the cell cycle, apoptosis and ion balance (Johnson et al., 2007) . Previous studies have indicated that the mitochondria play an important role in cerebral I/R damage via ROS release and mitochondrial apoptosis (Chan, 2001; Liu et al., 2015) .
Recently, maresins (macrophage mediators in resolving inflammation) were identified as protective mediators that functioned as "stop signals" for inflammation when released by macrophages in the presence of docosahexaenoic acid (DHA) (Serhan et al., 2009; Serhan, 2014) . The human M2 macrophages release specific lipid mediators including Maresin 1(MaR1) in response to pathogenic bacteria (Werz et al., 2018) .
There is increasing evidence that MaR1 displays pro-resolving and anti-inflammatory activities in many diseases (Serhan, 2014; Serhan et al., 2012; M et al., 2018) . In our previous study, MaR1 was shown to significantly protect against I/R in the mouse brain by alleviating pro-inflammatory reactions and NF-κB P65 activation (Xian et al., 2016) . Also in spinal cord injury, MaR1 was found to promote inflammatory resolution, neuroprotection and functional recovery (I et al., 2017) . Sirtuin1 (SIRT1) is a nicotinamide adenine dinucleotide (NAD)-dependent deacetylase whose functions have been shown to correlate with metabolism, the cellular stress response, gene transcription, cell division and an increased lifespan (Bordone and Guarente, 2005) .
Up-regulation of SIRT1 in an Alzheimer's disease model was reported to promote neuronal survival (Kim et al., 2007) . Additionally, SIRT1 activation exerts protective effects on I/R injuries (Hsu et al., 2010; Tong et al., 2013) . SIRT1 expression is increased and plays a protective role in the ischemic preconditioning mechanism in the mouse heart (Nadtochiy et al., 2011) . In an acute stroke model, SIRT1 was shown to protect neurons by deacetylation and subsequently inhibit nuclear factor κB-induced inflammation (Hernández-Jiménez et al., 2013) . Moreover, the beneficial effects of melatonin, resveratrol and preconditioning against ischemic injury were partially SIRT1-dependent. Furthermore, SIRT1 and resolvin D1, an anti-inflammatory mediator, were positive co-operators in the resolution of endotoxin-induced uveitis in rats (Rossi et al., 2015) . However, the relationship between SIRT1 and MaR1 is unexplored. Therefore, in the present study, a middle cerebral artery occlusion (MCAO) mouse model was established to investigate the effects of MaR1 and SIRT1 on the inflammatory reactions and mitochondrial damage underlying cerebral I/R injury.
Results

MaR1 regulates the SIRT1, Ac-NF-κB, Bax and Bcl2 protein expression levels in the MCAO mouse.
Our previous study showed that MaR1 suppressed NF-κB nuclear translocation.
Because acetylation is essential for the transcriptional activity of NF-κB, and SIRT1 is an enzyme known to regulate acetylation, we performed Western blotting analysis to detect the SIRT1 and Ac-NF-κB protein contents in ischemic brain tissue. In Fig. 1a, 1 represents the sham group, 2 represents the MCAO group and 3 represents the MCAO+MaR1 group. Compared with the sham group, the SIRT1 and Bcl2 protein expression levels were decreased significantly and the Ac-NF-κB and Bax protein expression levels were increased markedly in mice that underwent MCAO (P<0.01, P<0.05). However, the increased Ac-NF-κB and Bax protein levels and decreased SIRT1 and Bcl2 protein levels in the MCAO mice were counteracted by treatment with MaR1.
Blocking the SIRT1 pathway affects MaR1 regulation of Ac-NF-κB, Bax and Bcl2.
To clarify whether the SIRT1 pathway was involved in the regulation of these proteins by MaR1, mice received EX527 intraperitoneally (5 mg/kg, every 2 days, for a total of 5 days before the MCAO operation) to inhibit SIRT1 activation before the MCAO operation. The SIRT1, Ac-NF-κB, Bax and Bcl2 protein levels in the mice are shown in Fig. 2 (1 represents the MCAO group, 2 represents the MCAO+MaR1 group, 3 represents the MCAO+MaR1+EX527 group, and 4 represents the MCAO+EX527 group). MaR1 administration up-regulated SIRT1 and Bcl2 but down-regulated Ac-NF-κB and Bax. However, after inhibiting the SIRT1 pathway, the regulatory effect of MaR1 on these proteins was blocked during cerebral I/R. Specifically, SIRT and Bcl-2 expression decreased significantly (P<0.001, P<0.05), whereas Ac-NF-κB and Bax expression increased (P<0.05, P<0.05). The results show that inhibiting SIRT1 exerts a resistant effect on regulation of the SIRT1, Ac-NF-κB, Bax and Bcl-2 protein levels by MaR1.
Blocking the SIRT1 pathway affects regulation of the pro-inflammatory factors
IL-1β, IL-6 and TNF-α by MaR1 in MCAO mice.
The levels of the inflammatory factors IL-1β, IL-6, TNF-α and IL-10 in the mice were evaluated using ELISA kits. The results showed that the IL-1β, TNF-α and IL-6 levels were significantly lower in the MCAO+MaR1 group than in the MCAO group (P<0.01, P<0.01, P<0.001; Fig. 3 ). The down-regulation of IL-1β, TNF-α and IL-6 by MaR1 was partially reversed after inhibiting the SIRT1 pathway with EX527 (P<0.05), although the expression levels were still significantly lower than those in the MCAO group. Meanwhile, no significant difference was found between the MCAO and MCAO+EX527 groups. Furthermore, MaR1 had nearly no effect on the expression of IL-10 in our experiment. Our results indicated that MaR1 exerted an anti-inflammatory effect on mice with an I/R injury that was associated with SIRT1.
Blocking SIRT1 influences regulation of the mitochondrial membrane potential by MaR1 in MCAO mice.
Mitochondrial dysfunction is an important mechanism of cerebral I/R injury, so we conducted additional experiments to determine whether MaR1 regulates mitochondrial healthy status and whether SIRT1 is related to the regulation. 
Blocking SIRT1 affects the protective effect of MaR1 on neurons after cerebral I/R.
To clarify whether the SRIT1 pathway was directly involved in the neuro-protective effect of MaR1, we observed neuronal degeneration, neuronal death and tissue injury by Fluoro-Jade B, TUNEL staining and H&E staining (Fig. 5) .
Consistent with our previously study, MaR1 significantly reduced the neuronal and the whole tissue injury (Xian et al., 2016) . However, with the administration of EX527, the neuro-protective ability of MaR1 was decreased significantly(p<0.05), reveled by increased neuronal degeneration and death(p<0.05, p<0.001), inflammatory cell infiltration, and neurocytes vacuolization or dissolution. It deserved to be mentioned that after blocking SIRT1 with EX527, MCAO mice treated with MaR1 still had less Fluoro-Jade B, TUNEL staining positive cells, vacuolated neurocytes and infiltrated inflammatory cells compared with mice in the MCAO model group. Furthermore, little difference in the neuronal damage situation was observed between mice in the MCAO model group and MCAO mice pre-treated with the SIRT1 inhibitor EX527.
The protective effects of MaR1 on cerebral I/R infarction, brain edema and neurological deficits are partially SIRT1-dependent.
To determine whether the protective effects of MaR1 on cerebral I/R infarction, brain edema, and neurological defects were related to the SIRT1 pathway, SIRT1 was blocked prior to MCAO modeling and MaR1 administration. The TTC staining and brain water content were performed at 48h after reperfusion, while neurological scores were evaluated at 24h and 72h after reperfusion. As shown in Figure 6 , MaR1 significantly reduced the infarct size of the ischemic brain (Fig. 6a. P<0.01 ), mitigated the brain edema (Fig. 6c. P<0.01) , and alleviated neurological deficits at 24h (Fig. 6b. (Fig. 6b. P<0.001) . After blocking SIRT1, the protective effect of MaR1 on cerebral infarction and brain edema were attenuated (P<0.05). However, only at 72h did EX527 affect the protection of MaR1 on neurological deficits. In addition, after blocking SIRT1, MaR1 treatment resulting in a smaller infarction and a lower brain water content than the MCAO group, implying that the protective effect of MaR1 was not completely alleviated. Furthermore, no significant differences in the infarct size, brain water content, and neurologic impairment were found between the MCAO+EX527 and MCAO groups.
P<0.01) or 72h
Discussion
Cerebral ischemia/reperfusion injury is a leading cause of mortality and disability worldwide. Therefore, current research is focused on the discovery of more effective therapeutic strategies to target ischemic brain injury, which is a major public health issue. A mouse MCAO model followed by reperfusion has been widely used to study ischemic mechanisms and potential interventions. In our present study, MaR1 was found to have brain protective effects during cerebral I/R injury in mice. However, these protective effects of MaR1 were partially inhibited by blocking SIRT1. The results revealed that MaR1 treatment significantly decreased the protein levels of the pro-inflammatory factors AC-NF-κB, Bax, IL-1β and TNF-α and increased the SIRT1 and Bcl-2 protein expression levels and the mitochondrial membrane potential. In addition, MaR1 treatment alleviated the neuronal injury and cerebral infarction in mice detected by Fluoro-Jade B staining, the neurological defect scores and TTC staining. However, these protective effects of MaR1 were partially reversed by blocking the SIRT1 signaling pathway. Therefore, SIRT1 may be one mechanism by which MaR1 exerts neuroprotective effects in MCAO mice.
MaR1 plays roles in tissue homeostasis and the resolution of inflammation and has remarkable anti-inflammatory properties (Serhan et al., 2009) . A previous study reported that MaR1 protected mice against experimental colitis, possibly by inhibiting the NF-κB pathway and enhancing the macrophage M2 phenotype (Marcon et al., 2013) .
Furthermore, MaR1 mitigated LPS-induced lung injury in mice by inhibiting neutrophil adhesion and decreasing the levels of pro-inflammatory cytokines (Gong et al., 2014) . Our present study provided evidence that MaR1 induced anti-inflammatory effects and inhibited the cerebral ischemia/reperfusion-induced decrease in the mitochondrial membrane potential to exert protective effects on cerebral I/R injury.
Inflammatory reactions are involved in cerebral damage after I/R injury. The inflammatory response is triggered immediately after ischemia and may lead to deterioration of delayed cerebral injury and poor functional prognosis of neurons (Han et al., 2015) . Inflammation and apoptosis require the expression of related genes, and the nuclear transcription factor NF-κB is the key to controlling the transcription of inflammatory and apoptosis-related genes. Our previous study revealed that MaR1 mitigated the acute inflammatory response in cerebral I/R injury(such as reducing the release of inflammatory factors and suppressing glial cell activation and neutrophil infiltration) probably through inhibiting NF-κB activation (Xian et al., 2016) .
Acetylation of lysine 310 of the NF-κB P65 subunit is a necessary condition for its complete transcriptional activity (Chen et al., 2002) . In the present study, administration of MaR1 significantly inhibited the P65 acetylation induced by cerebral ischemic reperfusion. Moreover, normal ΔΨm is a prerequisite for the maintenance of mitochondrial oxidative phosphorylation and the production of ATP. The decrease in ΔΨm is an early manifestation of apoptosis, and the cells will enter an irreversible apoptosis process following loss of the ΔΨm (Nadtochiy et al., 2011) . In the present study, MaR1 treatment preserved the ΔΨm and increased Blc-2 expression while decreasing Bax expression. However, these effects were reversed by the SIRT1 inhibitor EX527.
The acetylation status of P65 is regulated by a variety of acetylase and deacetylase enzymes. SIRT1 is a nicotinamide adenine dinucleotide (NAD+)-dependent protein deacetylase (Yu et al., 2014) . Previous studies reported that SIRT1 catalyzed the deacetylation of P65 at Lys310 and then inhibited its transcriptional activity and reduced apoptosis or inflammation (Yang et al., 2015) . The deacetylase activity of SIRT1 was also confirmed to be specifically involved in myocardial I/R injury . Activation of SIRT1 reduces oxidative stress and maintains mitochondrial function. For example, resveratrol protects against hyperglycemia-induced oxidative damage to mitochondria by activating SIRT1 in rat mesangial cells (Braidy et al., 2011). In addition, Yang et al. suggested that curcumin pretreatment significantly increased SIRT1 and decreased Ac-Foxo1 expression and exerted a significant anti-oxidative effect that was induced by myocardial I/R injury . In the present study, we focused on whether SIRT1 was involved in the protective effect of MaR1 on cerebral I/R injury. We found that MaR1 increased the SIRT1 protein expression level in MACO mice. Our results indicated that the protective effect of MaR1 on cerebral I/R injury could be partially reversed by SIRT1 inhibition.
In summary, our findings suggest that MaR1 treatment exerts a profound protective effect on cerebral I/R injury. This protection appears to be largely due to activation of SIRT1 signaling. These results reveal that MaR1 may be a promising candidate for the treatment of I/R injury in cerebral ischemic diseases.
Materials and methods
Regents.
The 7R-MaR1 was purchased from Cayman (Cayman Chemical, Ann Arbor, MI, USA). EX527, which is a selective SIRT1 inhibitor, was obtained from Selleck (Selleck Chemicals, Houston, TX, USA) and dissolved in dimethyl sulfoxide (DMSO).
Mouse MCAO model.
The mouse MCAO model was induced as previously reported (Longa et al., 1989) .
Mice were anesthetized with 80 mg/kg of 2% sodium pentobarbital by intraperitoneal injection. Silicon rubber-coated nylon suture was used to occlude the Middle cerebral artery. The occlusion was confirmed by a brain blood flow reduction of more than 75% of the baseline. After occlusion for one hour, the nylon suture was removed for reperfusion. Throughout the surgery, the rectal temperature was maintained at 37 ± 0.5 °C with a homeothermic blanket. Mice in the sham group underwent the same surgical procedures without insertion of the suture.
Animals and experimental group.
Mice weighing 23±2 g were purchased from the Hubei Provincial Center for Disease Control and Prevention (Wuhan, Hubei, China). The animals were housed under standard humidity and temperature conditions with a 12/12 h light/dark cycle. 
Western blotting analysis.
Cell homogenate was washed with PBS, and lysed with 10 mM Tris-HCl(pH7.5), 100mMNaCl, 1%NP-40, 50mMNaF, 2mMEDTA(pH8.0), 1 mM PMSF, 10 μg/ml leupeptin, and 10 μg/ml aprotinin. Total-protein samples (50 µg/lane) from tissues were separated using SDS-PAGE and transferred to PVDF membranes, which were blocked with 5% non-fat milk at room temperature for 3 h and then incubated (4°C, overnight) with primary antibodies against SIRT1(1:1000, Abcam, Cambridge, UK) , acetylated neuclear factor kappaB(AC-NF-κB), Bax and Bcl2 (1:1000, all from Cell Signaling Technology, Danvers, MA, USA). Next, the membranes were incubated (37°C, 1 h) with HRP conjugated secondary antibodies (1:3000, Boster, Wuhan, China). The proteins were detected with ECL (Thermo Fisher Scientific, Waltham, MA) and β-actin (1:1,000, Santa Cruz, Heidelberg, Germany) was used as a loading control. The intensity of the protein bands was ultimately analyzed using the Image J software (version 1.45s; NIH, Bethesda, MD, USA).
Determination of the IL-1β, IL-6, TNF-α and IL-10 levels.
The IL-1β, IL-6, TNF-α and IL-10 levels in the mouse ischemic tissues were evaluated using ELISA assays. Mouse brains derived from the ischemic tissues were homogenized using cold physiological saline and centrifuged at 4000 r/min at 4°C for 15 min to collect supernatants. The ELISA kits were obtained from Boster (Boster Biological Technology, Wuhan, China), and the assay was performed according to the manufacturer's instructions. The samples were measured in duplicate. Readings from each sample were normalized to the protein concentration.
Haematoxylin and Eosin(H&E), Fluoro-Jade B(FJ), Neu-N and terminal deoxynucleotidyl transferase-mediated dUTP nick end labelling (TUNEL) staining.
Briefly, formalin-fixed and paraffin-embedded 5 mm brain tissue sections (n=3 per group) were deparaffinized and hydrated; then, the sections were antigen repaired in citrate buffer using the microwave heating method. The slices underwent H&E to evaluate the cerebral pathology. Meanwhile, FJ staining was performed to assess neuronal degeneration(Millipore, Schwalbach, Germany) (Schmued et al., 1997) .
FJ-positive cells were observed using a fluorescence microscope(Olympus,Tokyo, Japan). The total number of FJ-positive cells in the ischemic hemisphere was counted in three different fields for each section by an investigator who was blinded to the studies. Furthermore, the neuronal death was detected by Neu-N and TUNEL staining.
Briefly, slices were immunostained by rabbit-anti-NeuN (1:300,Cell Signaling Technology, Danvers, MA, USA) and incubated in the TUNEL reaction mixture.
Measurement of neurological score, infarct volume and brain water content.
The neurological score was evaluated with an 18-point scale after 24 h or 72 h of reperfusion (Germano et al., 1994) . This neurological score is a composite of motor, sensory, reflex, and balance tests. In the severity scores of injury, 1 score point is awarded for the inability to perform the test or for the lack of a tested reflex; thus, the higher score, the more severe is the injury. The cerebral infarct volume was determined by 2,3,5-triphenyltetrazolium chloride (TTC) (Sigma, St. Louis, MO, USA) staining. Briefly, the slices were placed in a dark place with 2% TTC at 37 °C for 20 min, the normal brain tissue stained brick red, whereas the infarct area remained pale. Then, the infarct area was demarcated and analyzed using the Image J software (version 1.45s; NIH, Bethesda, MD, USA). Ischemic brains were dried in an oven at 100 °C to obtain the dry wight, and (wet weight-dried weight)/wet weight was used to calculate the brain water content.
Mitochondrial membrane potential measurement and electron microscopic analysis.
.In brief, after 0.5 g cortical tissue was homogenized in ice-cold MSH buffer (10 mM HEPES, pH 7.5, containing 200 mM mannitol, 70 mM sucrose, 1.0 mM EGTA and 2.0 mg/ml serum albumin), the homogenate was centrifuged at 1000g for 10 min at 4 °C. The collected supernatant was then centrifuged at 3500g for 10 min at 4 °C to obtain mitochondrial pellet.
Changes in mitochondrial membrane potential (ΔΨm) were measured using ΔΨm assay kit with JC-1 (Beyotime Institute of Biotechnology, China) according to the manufacturer's instructions. Briefly, isolated mitochondria were suspended in 0.5 ml medium containing 5 mM JC-1. After that, fluorescence was detected using a flow cytometer. Transmission electron microscope was used to evaluate the changes of mitochondria ultrastructure in the penumbra cortex. For estimation of mitochondrial ultrastructure, tissue samples were collected from the ischemic penumbra (Xie et al., 2018) , and the freshly prepared tissues were diced and fixed in 2.5% glutaraldehyde solution at 4 °C. Coronal sections (1.0 mm 3 ) of the penumbra of the ipsilateral cortex (1.2-0.2 mm rostral to bregma) were prepared and were post fixed in 2% osmium for 1 h, which were prior to impregnation in ethanol solutions of increasing concentrations. Subsequently, tissue segments were washed in propylene oxide and embedded in Epon 812 (TAAB, Berks, UK). Ultra-thin (60 nm) sections were cut with a diamond knife, stained with uranyl acetate and lead citrate, and were observed with an electron microscope (Hitachi,HT7700, Japan). Representative images of the mitochondria ultrastructure from three to four animals in each group are shown.
Statistical analysis.
Significant differences were determined using Dunnettʼs one-way analysis of 2.The down-regulation of the pro-inflammatory factors and up-regulation of mitochondrial membrane potential by MaR1 in MCAO mice was SIRT1 dependent.
3.SIRT1 was involved in the neuroprotective properties of MaR1.
